IP Library Granted Patent US 8,920,559
Granted Patent B2
US 8,920,559 · App. 12/888,052 · Granted Dec 30, 2014

Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,920,559
App. No.
12/888,052
Granted
Dec 30, 2014
Kind
B2
Abstract

The present disclosure relates to crystallizing a chemical substance(s) using ultrasound. Methods are provided for screening a chemical substance according to its solid forms by using ultrasound to generate new or unusual solid forms. Methods are also provided for crystallizing a chemical substance by novel techniques that include sonication. The present disclosure also relates to cocrystallization using ultrasound. Methods are provided for preparing cocrystals of an active agent and a guest by sonicating and crystallizing. Methods are also provided for screening a sample according to solid state phases (such as cocrystals and salts) and include generating a cocrystal from the sample using ultrasound.

Claims (6)

1. A cocrystal of fluoxetine hydrochloride and benzoic acid, wherein the cocrystal is prepared by sonicating a solution of fluoxetine hydrochloride and benzoic acid in acetonitrile.

2. A method of making a cocrystal of fluoxetine hydrochloride and benzoic acid, comprising:

sonicating a solution of fluoxetine hydrochloride and benzoic acid in acetonitrile.

3. The method of claim 2 , wherein the fluoxetine hydrochloride and benzoic acid are in about a 1:1 molar ratio.

4. The method of claim 2 , wherein the solution contains about 35 mg/mL to about 200 mg/mL fluoxetine hydrochloride and benzoic acid.

5. The method of claim 2 , wherein the solution contains about 35 mg/mL to about 100 mg/mL fluoxetine hydrochloride and benzoic acid.

Assignments (13)
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON SEPTEMBER 1, 2017, AT REEL/FRAME 043746/0621 Recorded Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
SECURITY INTEREST Recorded Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC); CURIA NEW MEXICO, LLC (FKA OSO BIOPHARMACEUTICALS MANUFACTURING, LLC); CURIA IP HOLDINGS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
Reel/Frame 054252/0687 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING LLC-BY ITS SOLE MEMBER:ALO ACQUISITION LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
FIRST LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC-BY ITS SOLE MEMBER: ALO ACQUISITION LLC
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded Aug 5, 2015
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 036257/0914 →
SECURITY INTEREST Recorded May 26, 2015
From: AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 035710/0880 →
CHANGE OF NAME Recorded Apr 23, 2015
From: AMRI AMERICIUM, LLC
To: AMRI SSCI, LLC
Reel/Frame 035487/0184 →
ASSIGNMENT EFFECTIVE 13 FEB 2015 Recorded Apr 23, 2015
From: APTUIT (WEST LAFAYETTE), LLC
To: AMRI AMERICIUM, LLC
Reel/Frame 035492/0830 →
MERGER Recorded Oct 25, 2014
From: SSCI, INC
To: APTUIT (KANSAS CITY), LLC
Reel/Frame 034034/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2014
From: CHILDS, SCOTT L.; MOUGIN-ANDRES, PATRICIA M.; STAHLY, BARBARA C.
To: SSCI, INC
Reel/Frame 034034/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2012
From: APTUIT (KANSAS CITY), LLC
To: APTUIT (WEST LAFAYETTE), LLC
Reel/Frame 027835/0137 →